Mitral Valve (Repair & Replacement)Monday, October 19, 2026
FDA Flags Edwards TMVR Delivery System After Fatality - Medical Product Outsourcing
1 min read·By E. Nolan Beckett, MD·Source: Medical Product Outsourcing
From The Valve Wire
The FDA has flagged a safety issue with an Edwards transcatheter mitral valve replacement delivery system following a reported fatality.
The trade coverage is thin on specifics, and we are not going to extrapolate beyond what has been confirmed: a device correction or safety communication tied to a delivery system, with a death in the reported event chain.
Context matters more than the headline.
TMVR remains the least mature of the structural heart platforms.
Source Abstract
FDA Flags Edwards TMVR Delivery System After Fatality Medical Product Outsourcing
Read the Original
Full article at Medical Product Outsourcing
Open at Medical Product Outsourcing →The Valve Wire summarizes; we link out to primary sources for verification.
More in Mitral Valve (Repair & Replacement)
- Mitral Valve (Repair & Replacement)· Annali italiani di chirurgiaMultidimensional Echocardiographic Parameters Predict Left Ventricular Functional Recovery After Coronary Artery Bypass Grafting.
- Mitral Valve (Repair & Replacement)· IndexBoxTissue Mitral Valve Replacements Market Forecast to 2035, Driven by Aging Population and Transcatheter Innovation - IndexBox
- Mitral Valve (Repair & Replacement)· Medical DailyFour Lots of Edwards Mitral Valve Delivery Systems Pulled After Balloon Bursts Linked to One Patient Death - Medical Daily
Elsewhere in Today’s Issue
- Aortic Valve (TAVR/TAVI)· Acta cardiologicaIntravascular imaging improves outcomes in left main PCI: insights from acute and chronic presentations.
- Aortic Valve (TAVR/TAVI)· Journal of nursing managementDevelopment and Initial Psychometric Validation of a Nurse-Assessed Discharge Readiness Scale for Patients With Coronary Heart Disease Following Percutaneous Coronary Intervention.
- Aortic Valve (TAVR/TAVI)· CureusUnmasking Brugada Syndrome With Oral Propafenone in a Resource-Limited Setting: A Case Report.